cogenital myasthenic syndromes

Catalyst Pharma's Firdapse bet on congenital myasthenic syndromes turns sour
Endpoints
Wed, 10/30/19 - 10:24 am
Catalyst Pharmaceutical Partners
FDA
Firdapse
cogenital myasthenic syndromes